Sergio Gonzales1, Michael T Mullen1, Lesli Skolarus1, Dylan P Thibault1, Uduak Udoeyo1, Allison W Willis2. 1. From the Leonard Davis Institute of Health Economics (S.G., M.T.M., A.W.W.), Center for Clinical Epidemiology and Biostatistics (D.P.T., A.W.W.), and Department of Biostatistics and Epidemiology (A.W.W.), University of Pennsylvania; Department of Neurology (S.G., M.T.M., D.P.T., A.W.W.), University of Pennsylvania School of Medicine, Philadelphia; Department of Neurology (L.S., A.W.W.), University of Michigan, Ann Arbor; and Dorsnsife School of Public Health (U.U.), Drexel University, Philadelphia, PA. 2. From the Leonard Davis Institute of Health Economics (S.G., M.T.M., A.W.W.), Center for Clinical Epidemiology and Biostatistics (D.P.T., A.W.W.), and Department of Biostatistics and Epidemiology (A.W.W.), University of Pennsylvania; Department of Neurology (S.G., M.T.M., D.P.T., A.W.W.), University of Pennsylvania School of Medicine, Philadelphia; Department of Neurology (L.S., A.W.W.), University of Michigan, Ann Arbor; and Dorsnsife School of Public Health (U.U.), Drexel University, Philadelphia, PA. allison.willis@uphs.upenn.edu.
Abstract
OBJECTIVE: To explore rural-urban differences and trends in tissue plasminogen activator (tPA) utilization among acute ischemic stroke (AIS) patients and examine the association between primary stroke center (PSC) growth and geographic disparity in tPA use. METHODS: We used hospital discharge data from the National Inpatient Sample (NIS) from 2000 to 2010 and indicators of tPA utilization and describe temporal trends in geographic disparities in AIS care during PSC growth. The Gini coefficient was used to quantify rural-urban inequity in tPA use at the state level (from 0% to 100% of maximum potential rural-urban inequity) in tPA use. RESULTS: Of 914,500 cases of AIS between 2001 and 2010, 2.3% (n = 21, 190) received tPA. The rural-urban disparity in tPA worsened: tPA use in urban hospitals quadrupled (1.17%-4.87%) compared to rural hospitals (0.87%-1.59%). Of 33 states with NIS data, 15 reached at least 75% of the maximum rural-urban inequality from 2004 to 2010. CONCLUSIONS: Geographic disparities in tPA use for AIS are increasing. Greater understanding of the effectors of tPA utilization is necessary to ensure that access to tPA treatment is equitable for all communities in the United States.
OBJECTIVE: To explore rural-urban differences and trends in tissue plasminogen activator (tPA) utilization among acute ischemic stroke (AIS) patients and examine the association between primary stroke center (PSC) growth and geographic disparity in tPA use. METHODS: We used hospital discharge data from the National Inpatient Sample (NIS) from 2000 to 2010 and indicators of tPA utilization and describe temporal trends in geographic disparities in AIS care during PSC growth. The Gini coefficient was used to quantify rural-urban inequity in tPA use at the state level (from 0% to 100% of maximum potential rural-urban inequity) in tPA use. RESULTS: Of 914,500 cases of AIS between 2001 and 2010, 2.3% (n = 21, 190) received tPA. The rural-urban disparity in tPA worsened: tPA use in urban hospitals quadrupled (1.17%-4.87%) compared to rural hospitals (0.87%-1.59%). Of 33 states with NIS data, 15 reached at least 75% of the maximum rural-urban inequality from 2004 to 2010. CONCLUSIONS: Geographic disparities in tPA use for AIS are increasing. Greater understanding of the effectors of tPA utilization is necessary to ensure that access to tPA treatment is equitable for all communities in the United States.
Authors: J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski Journal: Neurology Date: 2000-12-12 Impact factor: 9.910
Authors: Alexander T Schneider; Arthur M Pancioli; Jane C Khoury; Eric Rademacher; Alfred Tuchfarber; Rosemary Miller; Daniel Woo; Brett Kissela; Joseph P Broderick Journal: JAMA Date: 2003-01-15 Impact factor: 56.272
Authors: Michael T Swanoski; May Nawal Lutfiyya; Maria L Amaro; Michael F Akers; Krista L Huot Journal: BMC Public Health Date: 2012-06-01 Impact factor: 3.295
Authors: Andrew D Wilcock; Kori S Zachrison; Lee H Schwamm; Lori Uscher-Pines; Jose R Zubizarreta; Ateev Mehrotra Journal: JAMA Neurol Date: 2020-07-01 Impact factor: 18.302
Authors: Mehul D Patel; Gilson Honvoh; Antonio R Fernandez; Rhonda Cadena; Emma R Kelly; Philip McDaniel; Jane H Brice Journal: South Med J Date: 2019-06 Impact factor: 0.954
Authors: Richa Sharma; Kori S Zachrison; Anand Viswanathan; Marcelo Matiello; Juan Estrada; Christopher D Anderson; Mark Etherton; Scott Silverman; Natalia S Rost; Steven K Feske; Lee H Schwamm Journal: Circ Cardiovasc Qual Outcomes Date: 2020-03-04
Authors: Adam de Havenon; Kevin Sheth; Karen C Johnston; Alen Delic; Eric Stulberg; Jennifer Majersik; Mohammad Anadani; Shadi Yaghi; David Tirschwell; John Ney Journal: Neurology Date: 2021-10-14 Impact factor: 9.910
Authors: Morgan B Swanson; Aspen C Miller; Marcia M Ward; Fred Ullrich; Kimberly As Merchant; Nicholas M Mohr Journal: J Telemed Telecare Date: 2019-11-04 Impact factor: 6.344
Authors: George Howard; Dawn O Kleindorfer; Mary Cushman; D Leann Long; Adam Jasne; Suzanne E Judd; John C Higginbotham; Virginia J Howard Journal: Stroke Date: 2017-06-16 Impact factor: 7.914